Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

November 2015 - FRMC

Department

Conference Insider
12/21/2015

Alessia D'Anna

Alessia D'Anna
CMS submitted its letter outlining the 2016 prescription drug requirements to insurers in the federally facilitated marketplace.
CMS submitted its letter outlining the 2016 prescription drug requirements to insurers in the federally facilitated marketplace.
CMS submitted its letter...
12/21/2015
First Report Managed Care
Conference Insider
12/16/2015
Systematizing Patient-Centered Medical Home Transformation With the rise of patient-centered medical homes (PCMHs) and accountable care organizations (ACOs), it is important for managed care professionals to understand how these models can...
Systematizing Patient-Centered Medical Home Transformation With the rise of patient-centered medical homes (PCMHs) and accountable care organizations (ACOs), it is important for managed care professionals to understand how these models can...
Systematizing Patient-Centered...
12/16/2015
First Report Managed Care
Conference Insider
12/16/2015
Impaired mobility and walking in patients with multiple sclerosis (MS) negatively impacts all aspects of the patients’ lives.
Impaired mobility and walking in patients with multiple sclerosis (MS) negatively impacts all aspects of the patients’ lives.
Impaired mobility and walking in...
12/16/2015
First Report Managed Care
Conference Insider
12/16/2015
Interim analysis from the ongoing EMERALD [Evaluation of the Management of Infusion Reactions in Alemtuzumab- treated Patients] study will help provide additional guidance for optimizing the management of infusion-associated reactions (IARs)...
Interim analysis from the ongoing EMERALD [Evaluation of the Management of Infusion Reactions in Alemtuzumab- treated Patients] study will help provide additional guidance for optimizing the management of infusion-associated reactions (IARs)...
Interim analysis from the...
12/16/2015
First Report Managed Care
Conference Insider
12/16/2015
Relapses are one of the dis­tinctive features of relapsing-remitting multiple sclerosis (MS) and serve as the defining clinical presentation that leads to diagnosis and delivery of value-based care. There is uncertainty and het­erogeneity in...
Relapses are one of the dis­tinctive features of relapsing-remitting multiple sclerosis (MS) and serve as the defining clinical presentation that leads to diagnosis and delivery of value-based care. There is uncertainty and het­erogeneity in...
Relapses are one of the...
12/16/2015
First Report Managed Care
12/18/2015
  New Treatment for Hyperkalemia Current therapy options are limited and there is an increased risk of drug–drug interactions when patients take >1 potassium increasing drug. Hyperkalemia is defined as elevated serum potassium...
  New Treatment for Hyperkalemia Current therapy options are limited and there is an increased risk of drug–drug interactions when patients take >1 potassium increasing drug. Hyperkalemia is defined as elevated serum potassium...
  New Treatment for...
12/18/2015
First Report Managed Care
12/16/2015
Asthma can be difficult to treat, making it a challenge to manage in a value-based framework.  
Asthma can be difficult to treat, making it a challenge to manage in a value-based framework.  
Asthma can be difficult to...
12/16/2015
First Report Managed Care
Department
12/16/2015
MANAGING ASTHMA: Keys to Delivering Value-Based Care Asthma can be difficult to treat, making it a challenge to manage in a value-based framework.  
MANAGING ASTHMA: Keys to Delivering Value-Based Care Asthma can be difficult to treat, making it a challenge to manage in a value-based framework.  
MANAGING ASTHMA: Keys to...
12/16/2015
First Report Managed Care
Department
12/16/2015
Costs associated with psoriasis may be viewed from several different perspectives, including the patient, payer, and society.  
Costs associated with psoriasis may be viewed from several different perspectives, including the patient, payer, and society.  
Costs associated with psoriasis...
12/16/2015
First Report Managed Care
12/16/2015

Stephanie Vaccaro

Stephanie Vaccaro
Burden of Antibiotic Resistance: Stopping an Epidemic, Containing Cost​ Antibiotic resistance is exacting a high price in the US. In April 2011, the Centers for Dis­ease Control (CDC) reported that antibiotic resistance accounted for...
Burden of Antibiotic Resistance: Stopping an Epidemic, Containing Cost​ Antibiotic resistance is exacting a high price in the US. In April 2011, the Centers for Dis­ease Control (CDC) reported that antibiotic resistance accounted for...
Burden of Antibiotic Resistance:...
12/16/2015
First Report Managed Care

Advertisement

Advertisement

Advertisement